357 related articles for article (PubMed ID: 8336412)
1. [Correlation of regional wall motion and fatty acid metabolism in coronary artery disease, hypertension, and hypertrophic cardiomyopathy: assessment by dual-isotope SPECT with thallium-201 and iodine-123 beta-methyl fatty acid analogue].
Hase M; Nakata T; Yonekura S; Tsuchihashi K; Kobayashi H; Nagao K; Tanaka S; Kubota M; Tsuda T; Iimura O
Kaku Igaku; 1993 May; 30(5):529-39. PubMed ID: 8336412
[TBL] [Abstract][Full Text] [Related]
2. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O
J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529
[TBL] [Abstract][Full Text] [Related]
3. Impairment of regional fatty acid uptake in relation to wall motion and thallium-201 uptake in ischaemic but viable myocardium: assessment with iodine-123-labelled beta-methyl-branched fatty acid.
Taki J; Nakajima K; Matsunari I; Bunko H; Takada S; Tonami N
Eur J Nucl Med; 1995 Dec; 22(12):1385-92. PubMed ID: 8586083
[TBL] [Abstract][Full Text] [Related]
4. [Is myocardial fatty acid metabolism different between hypertrophic cardiomyopathy and hypertensive hypertrophy?].
Narita M; Kurihara T; Usami M; Honda M
Kaku Igaku; 1994 Dec; 31(12):1465-76. PubMed ID: 7861646
[TBL] [Abstract][Full Text] [Related]
5. Impairment of BMIPP uptake precedes abnormalities in oxygen and glucose metabolism in hypertrophic cardiomyopathy.
Tadamura E; Kudoh T; Hattori N; Inubushi M; Magata Y; Konishi J; Matsumori A; Nohara R; Sasayama S; Yoshibayashi M; Tamaki N
J Nucl Med; 1998 Mar; 39(3):390-6. PubMed ID: 9529280
[TBL] [Abstract][Full Text] [Related]
6. [Prediction of left ventricular functional recovery in patients with acute myocardial infarction using single photon emission computed tomography with thallium-201 and iodine-123-beta-methyl-p-iodophenyl-pentadecanoic acid].
Hashimoto A; Nakata T; Nagao K; Kobayashi H; Hase M; Yoshioka N; Tsuchihashi K; Yonekura S; Tanaka S; Iimura O
J Cardiol; 1995 Aug; 26(2):59-68. PubMed ID: 7674145
[TBL] [Abstract][Full Text] [Related]
7. Detection of impaired fatty acid metabolism and dyskinesis in hypertrophic cardiomyopathy with iodine-123-BMIPP.
Nakata T; Tanaka S; Hamagami S; Miyamoto K; Oh-hori K; Iimura O
J Nucl Med; 1996 Oct; 37(10):1679-81. PubMed ID: 8862308
[TBL] [Abstract][Full Text] [Related]
8. Assessment of improvement of myocardial fatty acid uptake and function after revascularization using iodine-123-BMIPP.
Taki J; Nakajima K; Matsunari I; Bunko H; Takata S; Kawasuji M; Tonami N
J Nucl Med; 1997 Oct; 38(10):1503-10. PubMed ID: 9379183
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between ventricular arrhythmias and myocardial fatty acid metabolism in patients with coronary heart disease: evaluation using iodine-123 beta-methyl-p-iodophenyl-pentadecanoic acid].
Mori H; Sakamoto T; Ueda Y; Yano K
J Cardiol; 1999 Aug; 34(2):61-9. PubMed ID: 10466087
[TBL] [Abstract][Full Text] [Related]
10. Assessment of fatty acid uptake in ischemic heart disease without myocardial infarction.
Tateno M; Tamaki N; Yukihiro M; Kudoh T; Hattori N; Tadamura E; Nohara R; Suzuki T; Endo K; Konishi J
J Nucl Med; 1996 Dec; 37(12):1981-5. PubMed ID: 8970518
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of 123I-BMIPP myocardial SPECT in patients with hypertensive heart disease and hypertrophic cardiomyopathy: comparison with the findings of 201Tl SPECT and Gd enhanced magnetic resonance imaging].
Miyanaga H; Kawasaki S; Yoneyama S; Hyougo T; Kamitani T; Takahashi T; Kunishige H
Kaku Igaku; 1997 Feb; 34(2):85-93. PubMed ID: 9095571
[TBL] [Abstract][Full Text] [Related]
12. Myocardial metabolism of 123I-BMIPP in patients with hypertrophic cardiomyopathy: assessment by radial long-axis SPET.
Chen SL; Uehara T; Morozumi T; Yamagami H; Kusuoka H; Nishimura T
Nucl Med Commun; 1995 May; 16(5):336-43. PubMed ID: 7659385
[TBL] [Abstract][Full Text] [Related]
13. [Clinical implications of mismatched uptakes of beta-methyl fatty acid analogue and thallium in infarcted myocardium: correlations with coronary stenosis and regional wall motion abnormality].
Nakata T; Hashimoto A; Miyamoto K; Fujimori K; Shogase T; Hirasawa K; Ogata H; Fujiwara T; Mita T; Katoh J
Kaku Igaku; 1995 Oct; 32(10):1061-71. PubMed ID: 8523828
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneous myocardial distribution of iodine-123 15-(p-iodophenyl)-3-R,S-methylpentadecanoic acid (BMIPP) in patients with hypertrophic cardiomyopathy.
Takeishi Y; Chiba J; Abe S; Tonooka I; Komatani A; Tomoike H
Eur J Nucl Med; 1992; 19(9):775-82. PubMed ID: 1396872
[TBL] [Abstract][Full Text] [Related]
15. Myocardial sympathetic denervation, fatty acid metabolism, and left ventricular wall motion in vasospastic angina.
Watanabe K; Takahashi T; Miyajima S; Hirokawa Y; Tanabe N; Kato K; Kodama M; Aizawa Y; Tazawa S; Inoue M
J Nucl Med; 2002 Nov; 43(11):1476-81. PubMed ID: 12411551
[TBL] [Abstract][Full Text] [Related]
16. Increased uptake of iodine-123-BMIPP in chronic ischemic heart disease: comparison with fluorine-18-FDG SPECT.
Sloof GW; Visser FC; Bax JJ; van Lingen A; Eersels J; Knapp FF; Teule GJ
J Nucl Med; 1998 Feb; 39(2):255-60. PubMed ID: 9476931
[TBL] [Abstract][Full Text] [Related]
17. [Relationship between reduced myocardial uptake of beta-methyl-p-(123I)- iodophenyl-pentadecanoic acid (123I-BMIPP) and regional diastolic ventricular dysfunction in patients with hypertrophic cardiomyopathy].
Morozumi T; Ishida Y; Hori M; Kamada T; Yamagami H; Kozuka T; Kusuoka H; Nishimura T
Kaku Igaku; 1993 Sep; 30(9):1037-47. PubMed ID: 8230824
[TBL] [Abstract][Full Text] [Related]
18. Impairment of BMIPP accumulation at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy.
Ohtsuki K; Sugihara H; Kuribayashi T; Nakagawa M
J Nucl Med; 1999 Dec; 40(12):2007-13. PubMed ID: 10616878
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous dual myocardial imaging with iodine-123-beta-methyl iodophenyl-pentadecanoic acid (BMIPP) and thallium-201 in patients with coronary heart disease.
Tawarahara K; Kurata C; Taguchi T; Aoshima S; Okayama K; Kobayashi A; Yamazaki N; Kaneko M
Jpn Circ J; 1994 Feb; 58(2):107-15. PubMed ID: 8196152
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphy using 123I-labelled 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (123I-BMIPP).
Ohtsuki K; Sugihara H; Umamoto I; Nakamura T; Nakagawa T; Nakagawa M
Nucl Med Commun; 1994 Jun; 15(6):441-7. PubMed ID: 8078640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
